Bio-Rad Laboratories, Inc.Class A

BIONYSEUSD
287.74 USD
1.00 (0.35%)AT CLOSE (11:59 AM EDT)
287.87
0.13 (0.04%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
287.87
0.13 (0.04%)
🔴Market: CLOSED
Open?$287.49
High?$291.47
Low?$286.20
Prev. Close?$286.74
Volume?273.2K
Avg. Volume?397.5K
VWAP?$288.17
Rel. Volume?0.69x
Bid / Ask
Bid?$281.31 × 40
Ask?$292.00 × 120
Spread?$10.69
Midpoint?$286.66
Valuation & Ratios
Market Cap?7.7B
Shares Out?21.7M
Float?18.1M
Float %?83.4%
P/E Ratio?45.62
P/B Ratio?1.12
EPS?$6.31
Dividend?0.00%
Ex-Dividend?N/A

Bio-Rad Laboratories, Inc.Class A (BIO) is currently trading at $287.74. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score and a bearish Death Cross on the long-term moving averages. On valuation, BIO trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of May 22, 2026.

News
Profile
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Employees
7.5K
Market Cap
7.7B
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Listed
1980-02-29
Address
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: (510) 724-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+1/3)
Medium-Term (Wave)? Bullish(+2/3)
Short-Term (Ripple)? Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
78
Momentum?
60
Short Sent.?
69
Piotroski F-Score?3/9Weak
Altman Z-Score?3.26Safe
Confidence?65%Moderate
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?6.03%Elevated
Short Interest?1.1M
Days to Cover?3.7
Free Float18.1M
Avg Daily Volume295.8K
Settlement Date2026-04-30
Financial Health
Current Ratio?3.21Strong
Quick Ratio?2.37Strong
Cash Ratio?0.55Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
67/100
P/E?
Peers
30
S&P
15
45.6PRICEY
P/B?
Peers
90
S&P
94
1.12CHEAP
P/S?
Peers
82
S&P
51
2.97CHEAP
P/FCF?
Peers
82
S&P
50
21.6FAIR
EV/EBITDA?
Peers
18
S&P
7
36.4HIGH
EV/Sales?
Peers
82
S&P
57
3.24FAIR
Returns & Efficiency
ROE?
Peers
22
S&P
17
2.5%WEAK
ROA?
Peers
10
S&P
17
1.7%WEAK
Cash Flow & Enterprise
FCF?$357.2M
Enterprise Value?$8.4B
Fundamentals ratios updated end of day